and CAMBRIDGE, United Kingdom, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq ... has approved a 1-for-100 reverse stock split of the Company’s common stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback